Indonesia is the world's ‘most-flourishing' country. What does that mean?
Advertisement
The
Global Flourishing Study (GFS), written by researchers in Harvard, Baylor University and Gallup, asked more than 200,000 respondents in 23 countries and territories about five aspects of their life: happiness and life satisfaction, mental and physical health, meaning and purpose, character and virtue, and close social relationships.
Conducted between 2022 and 24, it aims to expand the scope of the annual World Happiness Report, which often features Nordic nations as the world's happiest countries. But that barometer does not capture the 'fullness of well-being', the scientists behind GFS – Byron Johnson, Tyler J. VanderWeele and Brendan Case – wrote in an op-ed in The New York Times on April 30.
'These rankings reinforce a key supposition of our globalised political and economic order: poor countries are unhappy because they are poor, and wealth is a critical precondition for individual and societal flourishing,' the scientists wrote.
'The three of us conceive of happiness, or flourishing, more broadly: as a state of affairs in which all aspects of your life are relatively good, including the social environments in which you live.'
Advertisement
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
8 hours ago
- South China Morning Post
China vows stronger biotech support as deals with global pharmaceutical giants surge
Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster innovation in a sector that has witnessed a boom in recent years. 'The biopharmaceutical industry is both a strategic emerging sector and vital to public health,' he said during an inspection in Beijing on Wednesday, as reported by the state-run Xinhua News Agency. 'Efforts should be made to strengthen original innovation, address core technological challenges and mobilise resources from the government and market to achieve breakthroughs quickly.' Li also urged research institutes to focus on global frontiers and critical areas, while training top talent to establish a solid foundation for the sector's development. His remarks came as Chinese biotech developers continue to sign increasing numbers of out-licensing agreements with multinational pharmaceutical companies. Out-licensing involves biotech firms selling drug candidates, which have often completed Phase I and II trials in China, to global partners. Chinese drug developers have widely adopted the model to ease financial pressures in an industry where embracing new therapeutic approaches has proven cash-intensive and carries a high risk of failure. With China's healthcare system largely government-funded, steep price cuts under its national insurance scheme also limit domestic profitability.
South China Morning Post
a day ago
- South China Morning Post
Could Hong Kong scientists fight age-related muscle loss with help of HIV drug?
Hong Kong scientists have identified an HIV drug that could be used to treat a common condition behind age-related muscle loss, with researchers hoping to start clinical trials next year. Researchers from the Chinese University of Hong Kong (CUHK) said on Wednesday that they had tested the HIV drug, known as Maraviroc, on 18-month-old mice suffering from sarcopenia, a progressive age-related condition that causes loss of muscle mass and strength. The study found that mice saw significant improvements in their muscle mass, grip strength and running endurance after receiving high doses of the drug for three months. Dr Michael Ong Tim-yun, a clinical assistant professor at CUHK's orthopaedics and traumatology department, said one in seven people aged 65 and above in Hong Kong suffered from sarcopenia, with the amount rising to 50 per cent of residents over the age of 80. 'This figure might be an underestimation as many patients who actually have symptoms of sarcopenia are not aware of it,' Ong said. Ong, who is part of the research team, explained that sarcopenia could be diagnosed by measuring a person's muscle mass, handgrip strength and walking speed. The only treatments currently available are exercise and protein supplementation, with no drugs used to treat the condition at this point.
South China Morning Post
a day ago
- South China Morning Post
Chinese studio behind Black Myth: Wukong plans new game featuring Taoist ghost hunter
The Chinese video game studio behind the global hit Black Myth: Wukong, which played a role in shifting Beijing's attitude on the gaming industry, has begun developing a new title featuring a Taoist ghost hunter from Chinese folklore. Hangzhou-based Game Science, whose Wukong featured the Monkey King from the classic Chinese novel Journey to the West, said it had started developing a follow-up title called Black Myth: Zhong Kui. The announcement was made at Gamescom 2025 in Cologne, Germany. Feng Ji, the studio's founder, said the new title would feature 'a new hero, new gameplay, new visuals, new technology, and a new story', even though it would still be a single player console game. A short video demonstration of the game had received more than 9 million views on Chinese game fan platform Bilibili as of Wednesday afternoon. Black Myth: Zhong Kui was also one of the most searched terms on Chinese social media Weibo on Wednesday, with more than 300 million people discussing the topic. A promotional image from Black Myth: Zhong Kui. Photo: Handout Game Science did not provide a release schedule for the new game as it was still in the early stage of development.
